Pages that link to "Q35788362"

The following pages link to MLL fusions: pathways to leukemia (Q35788362):

Displaying 46 items.

• The epigenetic landscape of acute myeloid leukemia (Q21284742) (← links)
• Proteasome inhibitors evoke latent tumor suppression programs in pro-B MLL leukemias through MLL-AF4 (Q24294703) (← links)
• Direct and Propagated Effects of Small Molecules on Protein-Protein Interaction Networks (Q26784027) (← links)
• The contribution of molecular epidemiology to the identification of human carcinogens: current status and future perspectives (Q26830046) (← links)
• Overexpression of the catalytically impaired Taspase1 T234V or Taspase1 D233A variants does not have a dominant negative effect in T(4;11) leukemia cells (Q28483263) (← links)
• The broken MLL gene is frequently located outside the inherent chromosome territory in human lymphoid cells treated with DNA topoisomerase II poison etoposide (Q28533804) (← links)
• Menin-MLL inhibitors reverse oncogenic activity of MLL fusion proteins in leukemia (Q30425903) (← links)
• Classifying leukemia types with chromatin conformation data (Q30835184) (← links)
• Discovering and understanding oncogenic gene fusions through data intensive computational approaches (Q31083417) (← links)
• Epigenetic control of immunity (Q33653705) (← links)
• Downregulation of RUNX1/CBFβ by MLL fusion proteins enhances hematopoietic stem cell self-renewal (Q33794291) (← links)
• Oncogenic activation of FOXR1 by 11q23 intrachromosomal deletion-fusions in neuroblastoma (Q34210060) (← links)
• Development of a multi-step leukemogenesis model of MLL-rearranged leukemia using humanized mice (Q34321077) (← links)
• The MMSET histone methyl transferase switches global histone methylation and alters gene expression in t(4;14) multiple myeloma cells. (Q34568855) (← links)
• A conserved role for human Nup98 in altering chromatin structure and promoting epigenetic transcriptional memory (Q34649355) (← links)
• Widely expressed Af17 is likely not required for embryogenesis, hematopoiesis, and animal survival. (Q34752889) (← links)
• Complex patterns of chromosome 11 aberrations in myeloid malignancies target CBL, MLL, DDB1 and LMO2. (Q35023429) (← links)
• Identification of CD34+ and CD34- leukemia-initiating cells in MLL-rearranged human acute lymphoblastic leukemia (Q35056301) (← links)
• Challenges and opportunities in targeting the menin-MLL interaction (Q35122366) (← links)
• Use of Genome Engineering to Create Patient Specific MLL Translocations in Primary Human Hematopoietic Stem and Progenitor Cells (Q35767483) (← links)
• Spatial organization of the mouse genome and its role in recurrent chromosomal translocations (Q35874015) (← links)
• Regulation of IL-20 Expression by Estradiol through KMT2B-Mediated Epigenetic Modification (Q36180432) (← links)
• Cell cycle control in acute myeloid leukemia. (Q36206479) (← links)
• ChREBP promotes the differentiation of leukemia-initiating cells to inhibit leukemogenesis through the TXNIP/RUNX1 pathways (Q37437486) (← links)
• p27kip1 maintains a subset of leukemia stem cells in the quiescent state in murine MLL-leukemia (Q37504409) (← links)
• Histone-modifying enzymes: regulators of developmental decisions and drivers of human disease. (Q37997085) (← links)
• Menin as a hub controlling mixed lineage leukemia (Q38029260) (← links)
• MicroRNAs mark in the MLL-rearranged leukemia (Q38111235) (← links)
• Taspase1: a 'misunderstood' protease with translational cancer relevance. (Q38666356) (← links)
• Nonreciprocal chromosomal translocations in renal cancer involve multiple DSBs and NHEJ associated with breakpoint inversion but not necessarily with transcription (Q39206408) (← links)
• Predicting Chemotherapy Resistance in AML. (Q39233284) (← links)
• Methylation-mediated repression of microRNA-143 enhances MLL-AF4 oncogene expression (Q39517680) (← links)
• The importin-alpha/nucleophosmin switch controls taspase1 protease function (Q39574027) (← links)
• Phosphorylation of MLL by ATR is required for execution of mammalian S-phase checkpoint (Q39659313) (← links)
• KMT2A promotes melanoma cell growth by targeting hTERT signaling pathway (Q41335241) (← links)
• Selectively targeting Mcl-1 for the treatment of acute myelogenous leukemia and solid tumors (Q41907705) (← links)
• Acute myeloid leukaemia at an early age: Reviewing the interaction between pesticide exposure and KMT2A-rearrangement (Q47102422) (← links)
• Induction of the 5S RNP-Mdm2-p53 ribosomal stress pathway delays the initiation but fails to eradicate established murine acute myeloid leukemia (Q48214371) (← links)
• Identification of novel small-molecule inhibitors targeting menin-MLL interaction, repurposing the antidiarrheal loperamide (Q49106909) (← links)
• A chromatin modifier genetic screen identifies SIRT2 as a modulator of response to targeted therapies through the regulation of MEK kinase activity. (Q53069742) (← links)
• Targeting the epigenome for treatment of cancer. (Q53201323) (← links)
• Facile target validation in an animal model with intracellularly expressed monobodies (Q57266571) (← links)
• TOP3A, a new partner gene fused to MLL in an adult patient with de novo acute myeloid leukaemia (Q58492915) (← links)
• Nucleoporin Gene Fusions and Hematopoietic Malignancies (Q59072645) (← links)
• MLL-AF9 leukemias are sensitive to PARP1 inhibitors combined with cytotoxic drugs (Q89777211) (← links)
• Breakage-Fusion-Bridge Events Trigger Complex Genome Rearrangements and Amplifications in Developmentally Arrested T Cell Lymphomas (Q92542160) (← links)